Biogen
BIIB
BIIB
860 hedge funds and large institutions have $20.1B invested in Biogen in 2024 Q4 according to their latest regulatory filings, with 130 funds opening new positions, 292 increasing their positions, 317 reducing their positions, and 158 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
860
Holders Change
-42
Holders Change %
-4.66%
% of All Funds
11.45%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
130
Increased
292
Reduced
317
Closed
158
Calls
$308M
Puts
$356M
Net Calls
-$47.1M
Net Calls Change
+$22.1M
Top Buyers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$405M |
| 2 |
D.E. Shaw & Co
New York
|
+$180M |
| 3 |
VanEck Associates
New York
|
+$148M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$113M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$83.3M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$483M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$230M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$177M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$154M |
| 5 |
ClearBridge Investments
New York
|
-$91.8M |
